Sodium Acetate Buffer

Summary

Sodium acetate buffer, 0.12 M, pH 7.4 as a diluent in the low temperature technique of dilute clot lysis time, is more effective in accelerating the velocity of lysis than phosphate buffer of similar pH and molarity. A uniform shape of the clot is maintained throughout the digestion in sodium acetate buffer and the end point of lysis is characteristically marked by an abrupt and sharply defined disintegration. Sodium acetate buffer can be employed advantageously in this technique not only to improve the observation but also to shorten the lysis times.

¹ Present address: Directorate General, Armed Forces Medical Services, DHQ, New Delhi-I, India.

² Academisch Ziekenhuis Sint Rafaël, Katholieke Universitteit Leuven, 3000 Leuven, Belgium.

• References

• 1 Chohan I. S, Singh I, Balakrishnan K. Fibrinolytic activity at high altitude and sodium acetate buffer. Thrombosis Diathesis et Haemorrhagica 1974; 32: 65
• 2 Dalby A, Mertz E. T. Effect of chloride and other ions on the activation of bovine plasminogen (Profibrinolysin). American Journal of Physiology 1957; 191: 505
• 3 Fearnley G. R. Spontaneous Fibrinolysis. The American Journal of Cardiology 1960; 6: 371
• 4 Fearnley G. R. Fibrinolysis. Arnold Publication; London: 1965
• 5 Fearnley G. R, Ferguson J. Presence of fibrinolytic activity in whole blood, masked by the clotting process. Clinical Science 1958; 17: 55
• 6 Fearnley G. R, Balmforth G. V, Fearnley E. Evidence of a diurnal rhythm: with a simple method of measuring natural fibrinolysis. Clinical Science 1957; 16: 645
• 7 Fearnley G. R, Chakrabarty R. Increase of blood fibrinolytic activity by testosterone. The Lancet 1962; 2: 128
• 8 Fearnley G. R, Chakrabarty R, Avis P. R. D. Blood fibrinolytic activity in diabetes mellitus and its bearing on ischaemic heart disease and obesity. British Medical Journal 1963; 1: 921
• 9 Gallimore M. J. Effect of diluents on blood clot lysis. Journal of Clinical Pathology 1967; 20: 234
• 10 MacFarlane R. G. Fibrinolysis following operation. The Lancet 1937; 1: 10
• 11 MacFarlane R. G, Pilling J. Observations on fibrinolysis, plasmin and antiplasmin content of human blood. The Lancet 1946; 2: 562
• 12 Marsh N. A, Vere D. W. A comparative account of standard and urinary urokinase. Clínica Chimica Acta 1967; 16: 389
• 13 Mullertz S. Mechanism of activation and effect of plasmin in blood. Acta Physiologica Scandinavica 38 supplementum 1956; 130
• 14 Singh I, Chohan I. S, Mathew N. T. Fibrinolytic activity in high altitude pulmonary oedema. Indian Journal of Medical Research 1969; 57: 210
• 15 Singh I, Chohan I. S. Blood coagulation changes at high altitude predisposing to pulmonary hypertension. British Heart Journal 1972; a 34: 611
• 16 Singh I, Chohan I. S. Abnormalities of blood coagulation at high altitude. International Journal of Biometerology 1972; b 16: 283
• 17 Singh I, Chohan I. S. Reversal of abnormal fibrinolytic activity, blood coagulation factors and platelet function in high altitude pulmonary oedema with Frusemide. International Journal of Biometeorology 1973; 17: 73
• 18 Singh I, Chohan I. S. Adverse changes in fibrinolysis, blood coagulation and platelet function in high altitude pulmonary oedema and their role in its pathogenesis. International Journal of Biometerology 1974; 18: 33